Report of the Independent Observers 19th Asian Games
Hangzhou, China 2022 / Independent Observer Team. - Montreal : World Anti-Doping Agency (WADA), 2024

2022 Anti-Doping Testing Figures / World Anti-Doping Agency (WADA). - Montreal : WADA, 2024

Contents:

• Executive Summary - pp. 2-9 (7 pages)
• Laboratory Report - pp. 10-39 (30 pages)
• Sport Report - pp. 40-155 (116 pages)
• Testing Authority Report - pp. 156-279 (124 pages)
• ABP Report-Blood Analysis - pp. 280-320 (41 pages)

Report Highlights:

• A 6.4% increase in the total number of samples (including urine, non-ABP blood and dried blood spot samples) analyzed and reported into ADAMS in 2022 (256,770) vs. 2021 (241,430); 

• An increase in the total percentage of AAFs year on year; 

• An increase in the total number of samples analyzed and reported by most WADA-accredited laboratories and WADA-approved laboratories into ADAMS in 2022 vs 2021. 

• An increase in the total number and percentage of non-ABP blood and DBS samples analyzed in 2022.  

• An increase of 1.4% in the number of ABP blood samples analyzed in 2022. 

• An increase in the total number of AAFs and % AAF for ERAs [including erythropoietin (EPO) and other EPO-receptor agonists], GHRFs and GC/C/IRMS tests in 2022.  

The World Anti-Doping Agency (WADA) has published its 2022 Testing Figures Report (2022 Report), which summarizes the results of all the samples WADA-accredited laboratories analyzed and reported in WADA’s Anti-Doping Administration and Management System (ADAMS) in 2022. 

The 2022 Report – which includes an Executive Summary and sub-reports by Laboratory, Sport, Testing Authority and Athlete Biological Passport (ABP) Blood Analysis – includes in- and out-of-competition urine samples, blood and ABP blood data, and the resulting Adverse Analytical Findings (AAFs) and Atypical Findings (ATFs). 

Dopingautoriteit Annual Report 2022 (Netherlands) / Anti-doping Authority Netherlands (Dopingautoriteit). - Capelle aan den IJssel : Dopingautoriteit, 2023

Contents:

Chapter 1 – Education
Chapter 2 – Doping control
Chapter 3 – Intelligence & Investigations
Chapter 4 – Disciplinary Proceedings
Chapter 5 – Legal Affairs
Chapter 6 – Scientific research
Chapter 7 – Knowledge management
Chapter 8 – Therapeutic Use Exemptions
Chapter 9 – International Affairs
Chapter 10 – People & organisation
--------------------------
Annex 1 - Financial overview
Annex 2 - Members of Advisory Board and Committees
Annex 3 - Personnel
Annex 4 - Overview of presentations and scientific publications
Annex 5 - Secondary positions
Annex 6 – Abbreviations
Annex 7 – Result management

KADA Annual Report 2022 / Korea Anti-Doping Agency (KADA). - Seoul : KADA, 2023

Rapport d'activité 2022 / Agence Française de Lutte contre le Dopage (AFLD). - Paris : AFLD, 2023

NADA Annual Report 2022 / National Anti Doping Agency of Germany. - Bonn : Nationale Anti Doping Agentur Deutschland (NADA), 2023
NADA Material No. 102

Report Attività Antidoping 2022 / Organizzazione Nazionale Antidoping (NADO Italia). - Roma : NADO Italia, 2023

Jaresbericht 2022 / Natonale Anti-Doping Agentur Austria (NADA Austria). - Wien : NADA Austria, 2023

Contents:

NADA Austria 

• Leitbild, Vision, Mission, Werte, Ziele, Qualitätsmanagement 
• Kommissionen 
• Mitarbeiter:innen 
• Nationale und internationale Kooperationen 
• Central European Anti-Doping Organization (CEADO) 

DopingkontrollSystem 

• Dopingkontrollprogramm 2022 
• Dopingkontrollstatistik 2022 

Medizin 

• Medikamentenabfrage - MedApp 
• Medizinische Ausnahmegenehmigungen 

Recht 

• Intelligence & Investigation 
• Überwachung der Einhaltung der Anti-Doping Bestimmungen 
• Rechtliche Klärung bezüglich der Veröffentlichung von Sanktionen 
• Verstöße gegen die Anti-Doping Bestimmungen 2022 

Information & Prävention 

• Verpflichtende Dopingprävention 
• Online - Individuelles Lernen 
• Onsite - Gemeinsames Lernen 
• Internationale Kooperationen 

Ausblick NADA Austria 

Anlagen